Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.83)
# 4,057
Out of 5,245 analysts
181
Total ratings
21.76%
Success rate
-10.48%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.32 | +581.82% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $3.64 | +5,394.51% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $7.99 | +137.80% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.09 | +266.97% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.39 | +8,268.20% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.22 | +490.06% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $10.46 | +100.76% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.05 | +1,328.57% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.20 | +25,354.55% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $2.21 | +5,329.86% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.34 | +530.91% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $1.19 | +7,463.03% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.21 | +106.30% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.89 | +311.31% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.7592 | +690.31% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.7011 | +14,163.30% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $3.40 | +5,782.35% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.18 | +819.54% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $5.46 | +288,361.54% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.92 | +6,213.13% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $34.41 | +597.57% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.85 | +9,311.76% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $12.13 | +65,852.18% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.28 | +446.88% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.00 | +2,900.00% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.69 | +752.88% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $1.42 | +1,167.61% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.50 | +100.00% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $76.94 | -68.81% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.5801 | +589,453.53% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.97985 | +1,938,972.31% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.32
Upside: +581.82%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $3.64
Upside: +5,394.51%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $7.99
Upside: +137.80%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.09
Upside: +266.97%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.39
Upside: +8,268.20%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.22
Upside: +490.06%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $10.46
Upside: +100.76%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.05
Upside: +1,328.57%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.20
Upside: +25,354.55%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $2.21
Upside: +5,329.86%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.34
Upside: +530.91%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $1.19
Upside: +7,463.03%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $9.21
Upside: +106.30%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.89
Upside: +311.31%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.7592
Upside: +690.31%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.7011
Upside: +14,163.30%
Nov 12, 2024
Reiterates: Buy
Price Target: $200
Current: $3.40
Upside: +5,782.35%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.18
Upside: +819.54%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $5.46
Upside: +288,361.54%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.92
Upside: +6,213.13%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $34.41
Upside: +597.57%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.85
Upside: +9,311.76%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $12.13
Upside: +65,852.18%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.28
Upside: +446.88%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.00
Upside: +2,900.00%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.69
Upside: +752.88%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $1.42
Upside: +1,167.61%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $76.94
Upside: -68.81%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.5801
Upside: +589,453.53%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.97985
Upside: +1,938,972.31%